Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3437]
News [7941]
Articles [64]
Editorials [9]
Conferences [213]
elearning [49]
New breast cancer drug defeats the Ras genes notorious for causing many types of cancer
New breast cancer drug defeats the Ras genes notorious for causing many types of cancer
Researchers discover new targets for approved cancer drug
Researchers discover new targets for approved cancer drug
New protein efficently cleans DNA breaks during chemotherapy
New protein efficently cleans DNA breaks during chemotherapy
New study finds more support is needed in Europe for breast cancer patient and survivors who wish to return to work
New study finds more support is needed in Europe for breast cancer patient and survivors who wish to return to work
Osimertinib granted breakthrough designation by FDA for 1st line treatment of patients with EGFRm positive NSCLC
Osimertinib granted breakthrough designation by FDA for 1st line treatment of patients with EGFRm positive NSCLC
NICE recommends access to venetoclax in England via Cancer Drugs Fund to treat most common form of adult leukaemia
NICE recommends access to venetoclax in England via Cancer Drugs Fund to treat most common form of adult leukaemia
Why can't mTOR inhibitors kill cancer?
Why can't mTOR inhibitors kill cancer?
Professor conducts research to combat pancreatic cancer
Professor conducts research to combat pancreatic cancer
A new CRISPR-engineered cancer model to test therapeutics
A new CRISPR-engineered cancer model to test therapeutics
No clear evidence that most new cancer drugs extend or improve life
No clear evidence that most new cancer drugs extend or improve life

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation